Pfizer Inc. is pursuing patent infringement actions against Apotex Inc., Apotex Corp. and Mylan Pharmaceuticals Inc.
In July 2010, the Company received notices from Apotex and from Mylan that they had…
Pfizer Inc. is pursuing a patent infringement action against Apotex, Mylan and Mylan Inc., Actavis Inc. and Actavis Pharma Manufacturing Pvt. Ltd., and Amneal Pharmaceuticals LLC.
In October 2010, the Company…
Allergan Inc.’s patent infringement suit against Exela PharmSci, Inc. and Apotex, Inc. remains pending.
In February 2007, the Company received a paragraph 4 invalidity and noninfringement Hatch-Waxman Act certification from Exela…
Apotex Inc. faces a patent infringement complaint by Allergan Inc. over Combigan(R) patents.
In May 2010, the Company received a paragraph 4 invalidity and non-infringement Hatch-Waxman Act certification from Apotex indicating…
Allergan Inc.’s patent infringement suit against Apotex, Inc., is ongoing in the U.S. District Court of Delaware.
In October 2007, the Company received a paragraph 4 invalidity and noninfringement Hatch-Waxman Act…
No trial date has been set for the litigation between Shire Ltd. and Apotex Inc., Apotex Corp. and Apotex Pharmaceutical Holdings Inc. for the alleged infringement of U.S. Patent Nos.…
Allergan Inc.’s consolidated patent infringement suit against Exela PharmSci Inc. and Apotex Inc. is ongoing in the U.S. District Court for the District of Delaware.
In February 2007, the Company and…
Apotex Inc.’s bid for the rehearing of Allergan Inc. and Roche Palo Alto LLC’s suit for the alleged infringement of U.S. Patent No. 5,110,493, is pending with the U.S. Court…
The U.S. District Court for the District of Delaware has scheduled a trial date for March 9, 2009, in Allergan Inc.’s consolidated patent infringement suit against Exela PharmSci Inc. and…
Shire Ltd. is pursuing a lawsuit against Apotex Inc., Apotex Corp. and Apotex Pharmaceutical Holdings Inc. for the alleged infringement of U.S. Patent Nos. 5,912,013 and 5,326,570.
The patents-at-issue cover an…